Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Guaifenesin 200 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Guaifenesin 200 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ephedrine hydrochloride 25 mg and guaifenesin 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ephedrine hydrochloride 25 mg and guaifenesin 200 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dyphylline + guaifenesin 200mg/100mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dyphylline + guaifenesin 200mg/100mg capsule |
Has basis of strength substance (attribute) |
False |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Guaifenesin 91.44 mg and theophylline 152.4 mg oral capsule |
Has basis of strength substance (attribute) |
False |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ephedrine sulfate 25 milligram and guaifenesin 400 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely ephedrine sulfate 25 milligram and guaifenesin 400 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ephedrine hydrochloride 25 mg and guaifenesin 200 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Diprophylline 200 mg and guaifenesin 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Diprophylline 200 mg and guaifenesin 200 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ephedrine hydrochloride 12.5 mg and guaifenesin 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ephedrine hydrochloride 12.5 mg and guaifenesin 200 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely diprophylline 100 milligram and guaifenesin 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely guaifenesin 183 milligram and theophylline 305 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
False |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Guaifenesin 1200mg /pseudoephedrine 120mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guaifenesin 1200mg /dextromethorphan 60mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guaifenesin 600mg /dextromethorphan 30mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guaifenesin 600mg /pseudoephedrine 60mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guaifenesin 1200mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guaifenesin 600mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guaifenesin 300mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Guaifenesin 600 mg prolonged-release oral tablet |
Has basis of strength substance (attribute) |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Guaifenesin 600 mg prolonged-release oral tablet |
Has precise active ingredient |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Guaifenesin-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely diprophylline 100 milligram and guaifenesin 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Diprophylline 200 mg and guaifenesin 200 mg oral tablet |
Has precise active ingredient |
False |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Guaifenesin 1 g oral tablet |
Has precise active ingredient |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Guaifenesin 800 mg oral tablet |
Has precise active ingredient |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Guaifenesin 575 mg oral tablet |
Has precise active ingredient |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely guaifenesin 600 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ephedrine sulfate 25 milligram and guaifenesin 400 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Guaifenesin 100 mg oral tablet |
Has precise active ingredient |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Guaifenesin 200 mg oral capsule |
Has precise active ingredient |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely guaifenesin 675 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Guaifenesin 300 mg oral capsule |
Has precise active ingredient |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely guaifenesin 1.2 gram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Guaifenesin 200 mg oral tablet |
Has precise active ingredient |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ephedrine- and guaifenesin-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ephedrine hydrochloride 25 mg and guaifenesin 200 mg oral tablet |
Has precise active ingredient |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing diprophylline and guaifenesin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ephedrine hydrochloride 12.5 mg and guaifenesin 200 mg oral tablet |
Has precise active ingredient |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Dyphylline + guaifenesin 200mg/100mg capsule |
Has precise active ingredient |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely guaifenesin 183 milligram and theophylline 305 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
False |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Guaifenesin 91.44 mg and theophylline 152.4 mg oral capsule |
Has precise active ingredient |
False |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Guaifenesin- and theophylline-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing brompheniramine and guaifenesin and hydrocodone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing brompheniramine and guaifenesin and hydrocodone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing chlorphenamine and guaifenesin and hydrocodone and pseudoephedrine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
4 |
Guaifenesin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Guaifenesin and pseudoephedrine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only guaifenesin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing guaifenesin and pseudoephedrine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Guaifenesin and pseudoephedrine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Brompheniramine and guaifenesin and hydrocodone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing only cetylpyridinium and guaifenesin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Chlorphenamine and guaifenesin and hydrocodone and pseudoephedrine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
4 |
Dextromethorphan and guaifenesin and pseudoephedrine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Dextromethorphan and guaifenesin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only dextromethorphan and guaifenesin and phenylpropanolamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing only codeine and guaifenesin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Codeine and guaifenesin and pseudoephedrine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing only dexbrompheniramine and guaifenesin and paracetamol and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
4 |
Product containing only diprophylline and guaifenesin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ephedrine and guaifenesin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only guaifenesin and theophylline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Guaifenesin and hydrocodone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only guaifenesin and phenylephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Guaifenesin and phenylephrine and phenylpropanolamine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Guaifenesin and phenylpropanolamine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Brompheniramine and guaifenesin and hydrocodone only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Ephedrine and guaifenesin only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only chlorphenamine and guaifenesin and hydrocodone and pseudoephedrine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
4 |
Guaifenesin and theophylline only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only diprophylline and guaifenesin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely guaifenesin 50 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely guaifenesin 50 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has precise active ingredient |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely guaifenesin 600 milligram and pseudoephedrine hydrochloride 60 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely guaifenesin 600 milligram and pseudoephedrine hydrochloride 60 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely guaifenesin 20 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely guaifenesin 20 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has precise active ingredient |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dextromethorphan hydrobromide 30 mg and guaifenesin 600 mg prolonged-release oral tablet |
Has basis of strength substance (attribute) |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Dextromethorphan hydrobromide 30 mg and guaifenesin 600 mg prolonged-release oral tablet |
Has precise active ingredient |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only dextromethorphan and guaifenesin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Guaifenesin 1.2 g and pseudoephedrine hydrochloride 120 mg prolonged-release oral tablet |
Has basis of strength substance (attribute) |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Guaifenesin 1.2 g and pseudoephedrine hydrochloride 120 mg prolonged-release oral tablet |
Has precise active ingredient |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Dextromethorphan hydrobromide 60 mg and guaifenesin 1.2 g prolonged-release oral tablet |
Has basis of strength substance (attribute) |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Dextromethorphan hydrobromide 60 mg and guaifenesin 1.2 g prolonged-release oral tablet |
Has precise active ingredient |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Dextromethorphan- and guaifenesin-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Brompheniramine maleate 400 microgram/mL and guaifenesin 40 mg/mL and hydrocodone bitartrate 1 mg/mL oral solution |
Has precise active ingredient |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Brompheniramine maleate 400 microgram/mL and guaifenesin 40 mg/mL and hydrocodone bitartrate 1 mg/mL oral solution |
Has basis of strength substance (attribute) |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely diprophylline 6.67 milligram/1 milliliter and guaifenesin 6.67 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely diprophylline 6.67 milligram/1 milliliter and guaifenesin 6.67 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has precise active ingredient |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely diprophylline 100 milligram and guaifenesin 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Diprophylline 200 mg and guaifenesin 200 mg oral tablet |
Has precise active ingredient |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely guaifenesin 183 milligram and theophylline 305 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Guaifenesin 91.44 mg and theophylline 152.4 mg oral capsule |
Has precise active ingredient |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely guaifenesin 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has precise active ingredient |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely guaifenesin 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ambroxol hydrochloride 3 milligram/1 milliliter and guaifenesin 10 milligram/1 milliliter and terbutaline sulfate 250 microgram/1 milliliter conventional release oral solution (clinical drug) |
Has precise active ingredient |
True |
Guaifenesin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |